1-(5-Bromo-3-(2,5-dimethyl-1H-pyrrol-1-yl)-2-fluorophenyl)ethanone

Catalog No. :
ACPMKF911
CAS No. :
1624260-58-7
Molecular Formula :
C14H13BrFNO
Molecular Weight :
310.17

IUPAC Name:1-(5-bromo-3-(2,5-dimethyl-1H-pyrrol-1-yl)-2-fluorophenyl)ethan-1-one

1-(5-Bromo-3-(2,5-dimethyl-1H-pyrrol-1-yl)-2-fluorophenyl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$332.00Login to see priceInquiryInquiry
1g95%$831.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Bromo-3-(2,5-dimethyl-1H-pyrrol-1-yl)-2-fluorophenyl)ethanone
IUPAC Name1-(5-bromo-3-(2,5-dimethyl-1H-pyrrol-1-yl)-2-fluorophenyl)ethan-1-one
MDL No.MFCD28125588
Molecular FormulaC14H13BrFNO
Molecular Weight310.17
SMILESCC(C1=CC(Br)=CC(N2C(C)=CC=C2C)=C1F)=O
InChI KeyANHOSYYKTNGAAR-UHFFFAOYSA-N
Synonym1-(5-BroMo-3-(2,5-diMethyl-1H-pyrrol-1-yl)-2-fluorophenyl)ethanone;1-[5-bromo-3-(2,5-dimethylpyrrol-1-yl)-2-fluorophenyl]ethanone;Ethanone, 1-[5-bromo-3-(2,5-dimethyl-1H-pyrrol-1-yl)-2-fluorophenyl]-
CAS No.1624260-58-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPMKF911 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVMJE178 route compound structure diagram
    ACVMJE178110-13-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPMKF911 route product structure diagram
    ACPMKF9111624260-58-7
Inquiry

2. ACPMKF911 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPMKF911 route product structure diagram
    ACPMKF9111624260-58-7
Inquiry

Comments (0)